Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interaction. (Q38277473)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

review article

1 reference

title

Epstein-Barr virus: the hematologic and oncologic consequences of virus-host interaction (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

R H Giller

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

publication date

1 January 1989

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

number of pages

1 reference

Critical Reviews in Oncology Hematology

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

page(s)

149-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

The discovery of Burkitt's lymphoma

30 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The history of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The transmission of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

A sarcoma involving the jaws in African children

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Malignant tumors in African children. With special reference to malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Clonal origin for individual Burkitt tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Determining the Climatic Limitations of a Children's Cancer Common in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The epidemiology of Burkitt's lymphoma: evidence for a causal association with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Herpes-Type Virus and Chromosome Marker in Normal Leukocytes after Growth with Irradiated Burkitt Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

MORPHOLOGICAL AND BIOLOGICAL STUDIES ON A VIRUS IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein–Barr Virus in Burkitt's Lymphoma and Nasopharyngeal Carcinoma: EBV DNA in Biopsies of Burkitt Tumours and Anaplastic Carcinomas of the Nasopharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Induction of ebna precedes the first cellular S-phase after ebv-infection of human lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Characteristics of Epstein-Barr virus activation of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus receptor expression is correlated to cell cycle phase

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus transforms precursor B cells even before immunoglobulin gene rearrangements

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Progenitor and pre-B lymphocytes transformed by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein–Barr Virus Replication in Oropharyngeal Epithelial Cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Replication of Epstein–Barr virus in human epithelial cells infected in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping, and endocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus receptors on human pharyngeal epithelia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Immortalization of human T lymphocytes after transfection of Epstein-Barr virus DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Persistence of the Entire Epstein-Barr Virus Genome Integrated into Human Lymphocyte DNA

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Sequential appearance of Epstein-Barr virus nuclear and lymphocyte-detected membrane antigens in B cell transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Cytotoxic T-cell clones discriminate between A- and B-type Epstein-Barr virus transformants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Protection of cottontop tamarins against Epstein-Barr virus-induced malignant lymphoma by a prototype subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Quantitative Evaluation of Epstein-Barr-Virus-Infected Mononuclear Peripheral Blood Leukocytes in Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Efficiency of transformation of lymphocytes by Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Haemagglutinins produced in vitro by human lymphoblastoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

EB virus-induced B lymphocyte cell lines producing specific antibody

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Human monoclonals from antigen-specific selection of B lymphocytes and transformation by EBV.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Lymphoproliferative diseases in immunocompromised hosts: the role of Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA).

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Atypical lymphocytes in acute infectious mononucleosis. Identification by multiple T and B lymphocyte markers.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Characterization of immunoregulatory T cells in EBV-induced infectious mononucleosis by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus infection and immunoregulation in man.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Activation of Suppressor T Cells during Epstein-Barr-Virus-Induced Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Large granular lymphocytes inhibit the in vitro growth of autologous Epstein-Barr virus-infected B cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Suppressor T cell clones from patients with acute Epstein-Barr virus-induced infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The Epstein-Barr virus as a model of virus-host interactions

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. I. Specificity and HLA restriction of effector cells reactivatedin vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Long-term T-cell-mediated immunity to Epstein-Barr virus in man. III. Activation of cytotoxic T cells in virus-infected leukocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Human cytotoxic T lymphocytes (CTL) against Epstein-Barr virus (EBV) infected cells: EBV specificity and involvement of major histocompatibility complex determinants in the lysis exerted by anti-EBV CTL toward HLA-compatible and allogeneic target ce

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr-virus-specific T-cell memory in renal-allograft recipients under long-term immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Oropharyngeal excretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus-positive Burkitt's lymphoma cells not recognized by virus-specific T-cell surveillance

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Transmission of infectious mononucleosis by transfusion of pre-illness plasma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Recovery of Epstein–Barr Virus from Genital Ulcers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Primary epstein-barr virus infections in african infants. I. Decline of maternal antibodies and time of infection

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Prevalence of oropharyngeal excreters of leukocyte-transforming agents among a human population

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Oral excretion of Epstein-Barr virus by healthy subjects and patients with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Prolonged oropharyngeal excretion of Epstein-Barr virus after infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Prospective studies of a group of Yale University freshmen. I. Occurrence of infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Variable Phenotypic Expression of an X-Linked Recessive Lymphoproliferative Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Infectious mononucleosis. Epstein-Barr-virus shedding in saliva and the oropharynx

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

EBV-determined nuclear antigen (EBNA)-positive cells in the peripheral blood of infectious mononucleosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Hypersensitivity reactions to antibacterial drugs in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Primary Epstein–Barr-Virus Infections in Acute Neurologic Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Bone marrow in nine cases of clinical glandular fever and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The atypical lymphocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Demonstration of increased platelet-bound IgG in infectious mononucleosis complicated by severe thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

INFECTIOUS MONONUCLEOSIS: AN UNSUSPECTED SOURCE ON ANTI-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Lymphadenopathy due to infectious mononucleosis: its confusion with malignant lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Incidence of heterophil antibody responses inchildren with infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Heterophil-negative infectious mononucleosis and mononucleosis-like illnesses. Laboratory confirmation of 43 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Otorhinolaryngologic Presentations of Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Thrombocytopenic purpura with infectious mononucleosis. Report of 2 cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

IgM and IgG platelet antibodies in a case of infectious mononucleosis and severe thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Fatal thrombocytopenia with cerebral hemorrhage in mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Reappraisal of the role of anti-i in haemolytic anaemia in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Severe haemolytic anaemia complicating infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Auto Anti-N Immunohemolytic Anemia in Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Infectious mononucleosis complicated by acute haemolytic anaemia with a positive Donath-Landsteiner reaction

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Aggravation of Congenital Spherocytosis during Infectious Mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Acquired Hemolytic Anemia Associated with Infectious Mononucleosis in a Patient with Congenital Pyruvate Kinase Deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Auto-immune haemolytic anaemia and thrombocytopenia complicating infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Granulocyte changes in infectious mononucleosis

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Antibody formation in infectious mononucleosis. II. Other 19S antibodies and false-positive serology

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The effect of T cells from patients with infectious mononucleosis on CFU-CGM proliferation: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Pleural effusions in congestive heart failure and in pericardial disease

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Burkitt's tumour in the West Nile District Uganda, 1961-5.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The American Burkitt's Lymphoma Registry: eight years' experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Absence of Epstein-Barr viral DNA in Amercian Burkitt's lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Identification and molecular cloning of the human Blym transforming gene activated in Burkitt's lymphomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Cell kinetics in Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

American Burkitt's lymphoma: a clinicopathologic study of 30 cases. I. Clinical factors relating to prolonged survival

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Treatment results of 54 American patients with Burkitt's lymphoma are similar to the African experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Childhood non-Hodgkin's lymphoma. The results of a randomized therapeutic trial comparing a 4-drug regimen (COMP) with a 10-drug regimen (LSA2-L2)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Final case reporting from the ugandan prospective study of the relationship between ebv and burktit's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

A comparison of Epstein-Barr virus-specific T-cell immunity in malaria-endemic and -nonendemic regions of Papua New Guinea.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Paired epstein-barr virus-carrying lymphoma and lymphoblastoid cell lines Burkitt's lymphoma patients: Comparative sensitivity to non-specific and to allo-specific cytotoxic responsesin vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Carcinogenic nitrosamines in Cantonese salt-dried fish

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Combined effect of the extracts from Croton tiglium, Euphorbia lathyris or Euphorbia tirucalli and n-butyrate on Epstein-Barr virus expression in human lymphoblastoid P3HR-1 and Raji cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Application of an Immunoenzymatic Method and an Immunoautoradiographic Method for a Mass Survey of Nasopharyngeal Carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

IgA antibody, antibody-dependent cellular cytotoxicity and prognosis in patients with nasopharyngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Nasopharyngeal carcinoma: Significance of changes in epstein-barr virus-related antibody patterns following therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Carcinoma of the nasopharynx. Eighteen years' experience with megavoltage radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Prognostic factors in nasopharyngeal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Combination chemotherapy with adramycin (NSC-123127) and dimethyl triazeno imidazole carboxamide (DTIC) (NSC-45388) in children with metastatic solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Treatment of nasopharyngeal carcinoma with human leukocyte interferon

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein Barr virus nuclear antigen positive lymphoma after cyclosporin A treatment in patient with renal allograft

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus (EBV) induced polyclonal and monoclonal B-cell lymphoproliferative diseases occurring after renal transplantation. Clinical, pathologic, and virologic findings and implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Lymphoproliferative disorders in cardiac transplant recipients are multiclonal lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Prophylactic acyclovir in patients receiving bone marrow transplants

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Fatal infectious mononucleosis in a family

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Acquired Agammaglobulinemia after a Life-Threatening Illness with Clinical and Laboratory Features of Infectious Mononucleosis in Three Related Male Children

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Immunopathology of X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Malignant lymphoma in the X-linked lymphoproliferative syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Non-Hodgkin's lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Opportunistic lymphoproliferations associated with Epstein-Barr viral DNA in infants and children with AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

An EBV genome carrying pre-B cell leukemia in a homosexual man with characteristic karyotype and impaired EBV-specific immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Central-nervous-system lymphoma related to Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Fatal epstein-barr virus-associated hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

The 1986 Walter Hubert lecture. Recent studies on a vaccine to prevent EB virus-associated cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

Varicella-zoster virus infection and immunization in the healthy and the immunocompromised host

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2889%2980009-5

7 January 2021

10.1016/S1040-8428(89)80009-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json

30 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2545365%20AND%20SRC:MED&resulttype=core&format=json